Pompe disease results in a Golgi-based glycosylation deficit in human induced pluripotent stem cell-derived cardiomyocytes

Raval KK, Tao R, White BE, De Lange WJ, Koonce CH, Yu J, Kishnani PS, Thomson JA, Mosher DF, Ralphe JC, Kamp TJ. Pompe disease results in a Golgi-based glycosylation deficit in human induced pluripotent stem cell-derived cardiomyocytes. J Biol Chem 290(5):3121-36, 2015.

Year:

2015

Tissue Type:

Cardiovasculure

Cell Type:

Cardiomyocytes

Organ Type:

System Type:

12 min read

Absract

Click to Read the full publication

Get In Touch

At Flexcell® International Corporation, we understand that our commitment to the highest quality products and customer service are core to our business. Reach out to us today to see how we can apply those principals to your business.